Aristo Bio-Tech and Lifescience Other Announcement
Aristo Bio-Tech sent a Reg 36(1)(b) web-link letter for its FY 2025-26 Annual Report to shareholders without email IDs. No financial or business event is disclosed.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Aristo Bio-Tech sent a Reg 36(1)(b) web-link letter for its FY 2025-26 Annual Report to shareholders without email IDs. No financial or business event is disclosed.
Aristo Bio-Tech submitted its annual SDD compliance certificate for FY 2025-26. The certificate confirms maintenance of the mandatory structured digital database for insider trading monitoring.
Aristo Bio-Tech and Lifescience Limited submitted its quarterly confirmation certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations for the period ended March 31, 2026. The Registrar and Share Transfer Agent, MUFG Intime India, confirmed compliance regarding the dematerialisation and listing of securities.